Venlafaxine : Menopausal disorders
Detail
Condition :
Menopausal disorders
Keywords :
Menopause, hot sweats, mood swings, anxiety, weight gain, oral tablet, menopausal symptoms, HRT, hormone replacement therapy, SNRI, unlicensed, selective noradreanline reuptake inhibitors.
BNF Codes :
Committee Recommendations
Date
Committee Name
Narrative
Traffic Light Status
06 May 2020
The Surrey & North West Sussex Area Prescribing Committee updated their recommendations in line with NICE guidance NG23 Menopause diagnosis and management in May 2020.
Venlafaxine is recommended for menopausal symptoms and a BLUE (with no information sheet) traffic light status has been agreed. Please refer to the Menopause -NG23 briefing paper attached below for further information (Page 13/14). SNRIs should not be routinely offered as a first line treatment for vasomotor symptoms.
Blue
Documents
Type
Document
Review Date
Supplementary documents (CCG specific documents)
No records returned.
Drugs
Below are listed drugs that are used to treat Menopausal disorders.
- Clonidine Blue
- Conjugated oestrogens Non Formulary
- Conjugated oestrogens with medroxyprogesterone Non Formulary
- Drospirenone Non Formulary
- Duavive Non Formulary
- Estradiol Green (see narrative)
- Estradiol with dydrogesterone Green
- Estradiol with levonorgestrel Green (see narrative)
- Estradiol with medroxyprogesterone Non Formulary
- Estradiol with norethisterone Green (see narrative)
- Estradiol with progesterone Green
- Ethinylestradiol Non Formulary
- Fezolinetant
- HRT - Gabapentinoids Blue
- Levonorgestrel intrauterine system Green (see narrative)
- Medroxyprogesterone Green (see narrative)
- Non-Hormonal lubricants Non Formulary
- Paroxetine Blue
- Progesterone Green (see narrative)
- St Johns Wort Non Formulary
- Tibolone Green